CIK 0001520262 · Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981007018
- Phone
- 00-353-1-772-8000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- 4 Planned sale EVP R&D, Chief Medical Officer sold 4,000 shares at $28.00 ($112,000)
- 144 Insider Sale of Securities
- 4 Planned sale EVP R&D, Chief Medical Officer sold 3,748 shares at $30.00 ($112,447)
- 144 Insider Sale of Securities
- 4 Planned sale EVP R&D, Chief Medical Officer sold 4,000 shares at $29.30 ($117,200)
- 144 Insider Sale of Securities
- 8-K Event Material agreement · New debt or obligation · Regulation FD disclosure
- 8-K Event Regulation FD disclosure · Other events
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Planned sale EVP R&D, Chief Medical Officer sold 9,000 shares at $30.38 ($273,442)
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Material agreement · Results of operations · New debt or obligation · Regulation FD disclosure
- 4 Planned sale EVP R&D, Chief Medical Officer sold 9,000 shares at $31.53 ($283,776)
- 144 Insider Sale of Securities
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Material agreement · Other events
- 8-K Event Executive or director change · Regulation FD disclosure
Page 7 of 97 · 1,927 filings